• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于单核细胞增生李斯特菌的无抗生素抗性基因抗原递送系统,适用于其他细菌载体和DNA疫苗。

Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.

作者信息

Verch Thorsten, Pan Zhen-Kun, Paterson Yvonne

机构信息

Department of Microbiology, University of Pennsylvania, Philadelphia 19104, USA.

出版信息

Infect Immun. 2004 Nov;72(11):6418-25. doi: 10.1128/IAI.72.11.6418-6425.2004.

DOI:10.1128/IAI.72.11.6418-6425.2004
PMID:15501772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC523039/
Abstract

Plasmids represent a powerful tool to rapidly introduce genes into bacteria and help them reach high expression levels. In vaccine development, with live vaccine vectors, this allows greater flexibility and the ability to induce larger antigen amounts through multiple gene copies. However, plasmid retention often requires antibiotic resistance markers, the presence of which has been discouraged in clinical applications by the Food and Drug Administration. Therefore, we developed a Listeria monocytogenes-Escherichia coli shuttle plasmid that is retained by complementation of D-alanine racemase-deficient mutant strains both in vitro and in vivo. Our technology potentially allows the production of antibiotic resistance marker-free DNA vaccines as well as bacterial vaccine vectors devoid of engineered antibiotic resistances. As a proof of concept, we applied the D-alanine racemase complementation system to our Listeria cancer vaccine platform. With a transplantable tumor model, we compared the efficacy of the new Listeria vector to that of an established vector containing a conventional plasmid carrying a tumor-specific antigen. Both vaccine vector systems resulted in long-term regression of established tumors, with no significant difference between them. Thus, the Listeria vaccine vector presented here potentially complies with Food and Drug Administration regulations and could be developed further for clinical use.

摘要

质粒是一种强大的工具,可快速将基因导入细菌并帮助它们达到高表达水平。在疫苗开发中,对于活疫苗载体而言,这提供了更大的灵活性,并能够通过多个基因拷贝诱导产生更多的抗原。然而,质粒的保留通常需要抗生素抗性标记,而美国食品药品监督管理局在临床应用中不鼓励使用这类标记。因此,我们开发了一种单核细胞增生李斯特菌-大肠杆菌穿梭质粒,该质粒可通过在体外和体内对D-丙氨酸消旋酶缺陷突变菌株进行互补来实现保留。我们的技术有可能生产无抗生素抗性标记的DNA疫苗以及不含工程化抗生素抗性的细菌疫苗载体。作为概念验证,我们将D-丙氨酸消旋酶互补系统应用于我们的李斯特菌癌症疫苗平台。利用可移植肿瘤模型,我们比较了新型李斯特菌载体与含有携带肿瘤特异性抗原的传统质粒的既定载体的疗效。两种疫苗载体系统均导致既定肿瘤的长期消退,二者之间无显著差异。因此,本文介绍的李斯特菌疫苗载体可能符合美国食品药品监督管理局的规定,并可进一步开发用于临床。

相似文献

1
Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.基于单核细胞增生李斯特菌的无抗生素抗性基因抗原递送系统,适用于其他细菌载体和DNA疫苗。
Infect Immun. 2004 Nov;72(11):6418-25. doi: 10.1128/IAI.72.11.6418-6425.2004.
2
Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.基于减毒李斯特菌的 HPV16 E7 疫苗在小鼠模型中的预防和治疗效果。
Int J Mol Med. 2012 Dec;30(6):1335-42. doi: 10.3892/ijmm.2012.1136. Epub 2012 Sep 20.
3
In vivo bactofection: listeria can function as a DNA-cancer vaccine.体内细菌转染:李斯特菌可作为一种DNA癌症疫苗发挥作用。
DNA Cell Biol. 2006 Mar;25(3):142-51. doi: 10.1089/dna.2006.25.142.
4
Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expression.用于基于营养肉汤选择具有重组抗原表达的减毒单核细胞增生李斯特菌菌株的稳定整合载体。
Clin Vaccine Immunol. 2008 Sep;15(9):1414-9. doi: 10.1128/CVI.00208-08. Epub 2008 Jul 23.
5
A novel "priming-boosting" strategy for immune interventions in cervical cancer.一种新型的宫颈癌免疫干预“启动-增强”策略。
Mol Immunol. 2015 Apr;64(2):295-305. doi: 10.1016/j.molimm.2014.12.007. Epub 2015 Jan 6.
6
Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.在小鼠肿瘤模型中,甲病毒介导的针对16型人乳头瘤病毒抗原免疫的卓越治疗效果:免疫途径的影响
Antivir Ther. 2004 Oct;9(5):733-42.
7
Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product.一种依赖自杀质粒提供必需基因产物的单核细胞增生李斯特菌疫苗株的致病性和免疫原性。
Infect Immun. 2005 Sep;73(9):5789-98. doi: 10.1128/IAI.73.9.5789-5798.2005.
8
Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection.重组乙型肝炎表面抗原(HBsAg)疫苗中肿瘤表位的多个拷贝可增强细胞毒性T淋巴细胞(CTL)反应,但不能增强肿瘤保护作用。
Virology. 2007 Nov 25;368(2):363-75. doi: 10.1016/j.virol.2007.06.041. Epub 2007 Aug 8.
9
Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress.用表达人乳头瘤病毒16型E7的重组单核细胞增生李斯特菌进行口服疫苗接种可使小鼠肿瘤消退。
Int J Cancer. 2002 Dec 20;102(6):629-37. doi: 10.1002/ijc.10759.
10
Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.减毒单核细胞增生李斯特菌在体内递送蛋白质抗原或抗原编码DNA和mRNA的不同活疫苗策略的比较。
Infect Immun. 2006 Jul;74(7):3946-57. doi: 10.1128/IAI.00112-06.

引用本文的文献

1
LADS: a powerful vaccine platform for cancer immunotherapy and prevention.LADS:用于癌症免疫治疗和预防的强大疫苗平台。
BMC Biol. 2024 Dec 18;22(1):291. doi: 10.1186/s12915-024-02086-7.
2
Bacteria-Based Nanoprobes for Cancer Therapy.基于细菌的纳米探针用于癌症治疗。
Int J Nanomedicine. 2024 Jan 23;19:759-785. doi: 10.2147/IJN.S438164. eCollection 2024.
3
[ Balanced Lethal Systems Expressing Cervical Cancer Antigen Genes: Construction and Basic Biological Characteristics].[表达宫颈癌抗原基因的平衡致死系统:构建及基本生物学特性]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1159-1166. doi: 10.12182/20231160210.
4
Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis.人乳头瘤病毒相关致癌作用的流行病学、分子发病机制、免疫发病机制、免疫逃逸机制及疫苗评估
Pathogens. 2023 Nov 23;12(12):1380. doi: 10.3390/pathogens12121380.
5
A Listeria ivanovii balanced-lethal system may be a promising antigen carrier for vaccine construction.李斯特菌(Listeria ivanovii)平衡致死系统可能是疫苗构建有前途的抗原载体。
Microb Biotechnol. 2022 Nov;15(11):2831-2844. doi: 10.1111/1751-7915.14137. Epub 2022 Sep 7.
6
Streptococcal bacterial components in cancer therapy.链球菌细菌成分在癌症治疗中的应用。
Cancer Gene Ther. 2022 Feb;29(2):141-155. doi: 10.1038/s41417-021-00308-6. Epub 2021 Mar 22.
7
Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer.HPV 感染及相关癌症的控制和治疗疫苗策略。
Recent Results Cancer Res. 2021;217:157-195. doi: 10.1007/978-3-030-57362-1_8.
8
as a Vector for Cancer Immunotherapy: Current Understanding and Progress.作为癌症免疫治疗的载体:当前的认识与进展
Vaccines (Basel). 2018 Jul 25;6(3):48. doi: 10.3390/vaccines6030048.
9
Engineering bacteria for diagnostic and therapeutic applications.用于诊断和治疗应用的工程菌。
Nat Rev Microbiol. 2018 Apr;16(4):214-225. doi: 10.1038/nrmicro.2017.172. Epub 2018 Feb 5.
10
A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.D-丙氨酸营养缺陷型活疫苗可有效预防金黄色葡萄球菌引起的致死性感染。
Virulence. 2018 Jan 1;9(1):604-620. doi: 10.1080/21505594.2017.1417723.

本文引用的文献

1
Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery.单核细胞增生李斯特菌对哺乳动物细胞的细菌转染:DNA递送的改进及机制
Gene Ther. 2003 Nov;10(24):2036-45. doi: 10.1038/sj.gt.3302105.
2
In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium.重组质粒在肠炎沙门氏菌鼠伤寒血清型疫苗株中的体外和体内稳定性
FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):111-9. doi: 10.1016/S0928-8244(03)00065-8.
3
Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts.
Vaccine. 2003 Mar 7;21(11-12):1187-94. doi: 10.1016/s0264-410x(02)00554-6.
4
Human papillomavirus and cervical cancer.人乳头瘤病毒与宫颈癌
Clin Microbiol Rev. 2003 Jan;16(1):1-17. doi: 10.1128/CMR.16.1.1-17.2003.
5
Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen.重组卡介苗(BCG)经直肠内/皮内联合接种可诱导针对插入的HIV-1 V3抗原的增强免疫反应。
Vaccine. 2002 Dec 13;21(3-4):158-66. doi: 10.1016/s0264-410x(02)00465-6.
6
Use of the alr gene as a food-grade selection marker in lactic acid bacteria.将alr基因用作乳酸菌中的食品级选择标记。
Appl Environ Microbiol. 2002 Nov;68(11):5663-70. doi: 10.1128/AEM.68.11.5663-5670.2002.
7
Mutant analysis shows that alanine racemases from Pseudomonas aeruginosa and Escherichia coli are dimeric.突变分析表明,铜绿假单胞菌和大肠杆菌的丙氨酸消旋酶是二聚体。
J Bacteriol. 2002 Aug;184(15):4321-5. doi: 10.1128/JB.184.15.4321-4325.2002.
8
Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors.两种单核细胞增生李斯特菌位点特异性噬菌体整合载体的构建、表征及应用
J Bacteriol. 2002 Aug;184(15):4177-86. doi: 10.1128/JB.184.15.4177-4186.2002.
9
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.两种表达人乳头瘤病毒16型(HPV - 16)E7不同分子形式的单核细胞增生李斯特菌疫苗载体诱导出性质不同的T细胞免疫,这与其诱导由HPV - 16永生化的已建立肿瘤消退的能力相关。
J Immunol. 2001 Dec 1;167(11):6471-9. doi: 10.4049/jimmunol.167.11.6471.
10
Gene cloning and characterization of alanine racemases from Shigella dysenteriae, Shigella boydii, Shigella flexneri, and Shigella sonnei.痢疾志贺氏菌、鲍氏志贺氏菌、福氏志贺氏菌和宋内氏志贺氏菌丙氨酸消旋酶的基因克隆与特性分析
Biochem Biophys Res Commun. 2001 Nov 2;288(3):676-84. doi: 10.1006/bbrc.2001.5817.